Tynept
Utilised to manage clinical depressive symptoms to alleviate emotional distress and support synaptic neurotransmitter modulation.
- Category
- Antidepressants
- Active ingredient
- Tianeptine
- Route
- Oral use
- Form
- Tablet
- Strengths
- 12.5mg
Prescription and consultation requirements for Tynept vary by destination and are determined by the fulfilment partner.
Tynept details
- Condition
- Major Depressive Disorder
- Alternative names
- tianeptine
- Therapeutic class
- Atypical Antidepressant
- Pharmacological class
- Antidepressant
- Known off-label uses
- generalised anxiety disorder
- Contraindications
- concurrent use of MAO inhibitors
- Minor side effects
- nausea; headache; dizziness
- Moderate side effects
- insomnia; dry mouth; constipation
- Dosage forms
- Tablet
- Administration route
- Oral use
- Supply category
- Prescription-only medicine (POM)
- Manufacturer
- Intas Pharmaceuticals Ltd
- Onset Time
- 1–2 weeks
- Duration
- 12 hours
- Storage instructions
- Store below 25°C.
- Drug interactions
- MAO Inhibitors
- Age restrictions
- Approved for adults.
Serious side effects
severe hepatotoxicity, requires immediate medical attention; suicidal ideation, requires immediate medical attention
Patient summary
utilised to manage clinical depressive symptoms to alleviate emotional distress and support synaptic neurotransmitter modulation.
Mechanism of action
Exerts novel neurochemical modulation, acting as a selective serotonin reuptake enhancer to stabilise neuroplasticity under chronic stress.
Pregnancy and breastfeeding
TGA Category C: Limited human data. Avoid during pregnancy unless benefits justify potential risks. Breastfeeding: Consult a doctor.